And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

FULC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $57,935.58

Fulcrum Therapeutics Insider Trading History Chart

Fulcrum Therapeutics Share Price & Price History

^$7.28

▼ -0.16 (-2.15%)

As of 04/24/2024 01:00 AM ET

Days: 30 | 90 | 365

He Is Giving Away Bitcoin

From Crypto Swap Profits | Ad

>> Register right here

Fulcrum Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/8/2024	Greg Tourangeau	VP	Sell	4,884	$11.72	$57,240.48	11,807
5/10/2023	Greg Tourangeau	Insider	Sell	210	$3.31	$695.10	15,992
1/20/2023	Ra Capital Management, L.P.	Major Shareholder	Buy	1,923,076	$13.00	$24,999,988.00	11,609,704
1/13/2023	Robert J. Gould	CEO	Sell	6,766	$15.00	$101,490.00	499,864
1/4/2023	Ra Capital Management, L.P.	Major Shareholder	Buy	180,703	$7.28	$1,315,517.84	9,686,628
12/27/2022	Ra Capital Management, L.P.	Major Shareholder	Buy	4,089	$5.99	$24,493.11	9,505,925
12/19/2022	Ra Capital Management, L.P.	Major Shareholder	Buy	98,787	$5.90	$582,843.30	9,501,836
12/16/2022	Ra Capital Management, L.P.	Major Shareholder	Buy	1,341,420	$5.42	$7,270,496.40	9,403,049
12/14/2022	Ra Capital Management, L.P.	Major Shareholder	Buy	824,600	$5.46	$4,502,316.00	7,824,600
6/6/2022	Robert J. Gould	Director	Sell	24,382	$8.10	$197,494.20	506,630
6/3/2022	Robert J. Gould	Director	Sell	25,551	$7.95	$203,130.45	506,630
4/7/2022	Robert J. Gould	Director	Sell	5,631	$24.02	$135,256.62	506,630
4/4/2022	Robert J. Gould	Director	Sell	7,235	$24.02	$173,784.70	506,630
4/1/2022	Robert J. Gould	Director	Sell	34,464	$24.03	$828,169.92	506,630
6/28/2021	Christopher Morabito	Insider	Buy	1,100	$9.16	$10,076.00	1,100
6/28/2021	Curtis Gale Oltmans	SVP	Buy	1,088	$9.01	$9,802.88	1,088
6/28/2021	James A. Geraghty	Director	Buy	10,000	$9.16	$91,600.00	90,714
6/28/2021	Peter G Thomson	VP	Buy	2,300	$9.00	$20,700.00

He Is Giving Away Bitcoin

From Crypto Swap Profits | Ad

>> Register right here

SEC Filings (Institutional Ownership Changes) for Fulcrum Therapeutics (NASDAQ:FULC)

89.83% of Fulcrum Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Fulcrum Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/19/2024	Denali Advisors LLC	27,100	$0.26M	0.1%	-53.1%	0.044%
4/4/2024	Mass General Brigham Inc	205,356	$1.94M	3.4%	N/A	0.332%
2/15/2024	Opaleye Management Inc.	130,000	$0.88M	0.2%	N/A	0.210%
2/14/2024	ADAR1 Capital Management LLC	637,405	$4.30M	1.5%	N/A	1.031%
2/14/2024	Vestal Point Capital LP	1,025,000	$6.92M	0.7%	N/A	1.658%
2/14/2024	RTW Investments LP	5,469,956	$36.92M	0.6%	-6.0%	8.848%
2/13/2024	Tower Research Capital LLC TRC	3,658	$25K	0.0%	-30.3%	0.006%
2/13/2024	Affinity Asset Advisors LLC	125,000	$0.84M	0.2%	N/A	0.202%
2/12/2024	Capstone Investment Advisors LLC	10,000	$68K	0.0%	N/A	0.016%
1/31/2024	abrdn plc	256,888	$1.73M	0.0%	N/A	0.416%
1/24/2024	China Universal Asset Management Co. Ltd.	7,150	$48K	0.0%	+348.6%	0.012%
1/19/2024	Denali Advisors LLC	57,800	$0.39M	0.1%	-18.1%	0.093%
12/7/2023	Hudson Bay Capital Management LP	196,488	$0.87M	0.0%	N/A	0.318%
12/6/2023	Citigroup Inc.	89,189	$0.40M	0.0%	+1,028.5%	0.144%
11/15/2023	RTW Investments LP	5,818,804	$25.84M	0.5%	-4.0%	9.412%
11/15/2023	Adage Capital Partners GP L.L.C.	2,406,422	$10.69M	0.0%	+4.3%	3.893%
11/14/2023	Brown Wealth Management LLC	25,000	$0.11M	0.1%	N/A	0.040%
11/13/2023	Algert Global LLC	31,010	$0.14M	0.0%	N/A	0.050%
11/13/2023	ClariVest Asset Management LLC	104,400	$0.46M	0.0%	N/A	0.169%
11/13/2023	FMR LLC	5,975,416	$26.53M	0.0%	+7.6%	9.666%
11/13/2023	DekaBank Deutsche Girozentrale	60,000	$0.27M	0.0%	N/A	0.097%
11/9/2023	Cowen AND Company LLC	4,308,359	$19.13M	1.3%	+38.2%	6.969%
11/9/2023	Citigroup Inc.	89,189	$0.40M	0.0%	+1,028.5%	0.144%
11/8/2023	Vivo Capital LLC	520,000	$2.31M	0.3%	-5.5%	0.841%
11/8/2023	Landscape Capital Management L.L.C.	28,252	$0.13M	0.0%	N/A	0.046%
11/7/2023	Jump Financial LLC	91,790	$0.41M	0.0%	N/A	0.148%
10/20/2023	Denali Advisors LLC	70,600	$0.31M	0.1%	N/A	0.114%
8/15/2023	Suvretta Capital Management LLC	5,718,881	$18.87M	1.0%	+10.5%	9.251%
8/14/2023	Prelude Capital Management LLC	11,171	$37K	0.0%	N/A	0.018%
8/14/2023	Graham Capital Management L.P.	31,948	$0.11M	0.0%	-78.3%	0.052%
8/11/2023	MYDA Advisors LLC	50,000	$0.17M	0.0%	N/A	0.081%
8/11/2023	Harvard Management Co. Inc.	341,972	$1.13M	0.1%	-16.7%	0.553%
8/10/2023	Tekla Capital Management LLC	256,888	$0.85M	0.0%	+338.8%	0.416%
8/7/2023	Cowen AND Company LLC	3,116,996	$10.29M	0.9%	+43.2%	5.042%
8/7/2023	Mirabella Financial Services LLP	32,760	$0.11M	0.0%	N/A	0.053%
7/28/2023	Marquette Asset Management LLC	27,867	$92K	0.0%	N/A	0.045%
5/15/2023	Suvretta Capital Management LLC	5,177,710	$14.76M	0.6%	+21.1%	8.384%
5/15/2023	RTW Investments LP	5,511,839	$15.71M	0.3%	+10.4%	8.925%
5/11/2023	Cornercap Investment Counsel Inc.	44,078	$0.13M	0.0%	+26.3%	0.071%
5/11/2023	Alphabet Inc.	14,262	$41K	0.0%	-94.4%	0.023%
5/10/2023	Simplify Asset Management Inc.	639,118	$1.82M	0.3%	N/A	1.035%
5/9/2023	Cowen AND Company LLC	2,176,045	$6.20M	0.7%	+59.9%	3.523%
5/9/2023	Y Intercept Hong Kong Ltd	29,663	$85K	0.0%	N/A	0.048%
5/8/2023	Zurcher Kantonalbank Zurich Cantonalbank	10,449	$30K	0.0%	+293.6%	0.017%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	32,274	$92K	0.0%	+137.8%	0.052%
5/1/2023	Virtu Financial LLC	31,104	$89K	0.0%	N/A	0.050%
4/28/2023	SG Americas Securities LLC	24,951	$71K	0.0%	+55.6%	0.040%
2/15/2023	Nantahala Capital Management LLC	500,000	$3.64M	0.2%	N/A	0.961%
2/14/2023	RA Capital Management L.P.	9,505,925	$69.20M	1.4%	+35.8%	18.263%
2/14/2023	VR Adviser LLC	447,326	$3.26M	0.5%	-62.7%	0.859%
2/14/2023	Alpine Global Management LLC	16,073	$0.12M	0.0%	N/A	0.031%
2/13/2023	Bessemer Group Inc.	286,988	$2.09M	0.0%	+0.4%	0.551%
2/13/2023	Cornercap Investment Counsel Inc.	34,886	$0.25M	0.0%	N/A	0.067%
2/10/2023	Tekla Capital Management LLC	58,537	$0.43M	0.0%	N/A	0.112%
2/9/2023	Landscape Capital Management L.L.C.	11,114	$81K	0.0%	N/A	0.021%
2/9/2023	Cowen AND Company LLC	1,361,169	$9.91M	1.0%	-42.0%	2.615%
2/2/2023	SG Americas Securities LLC	16,033	$0.12M	0.0%	+35.5%	0.031%
11/16/2022	Alphabet Inc.	255,452	$2.07M	0.1%	N/A	0.491%
11/16/2022	Sandia Investment Management LP	5,000	$40K	0.0%	N/A	0.010%
11/15/2022	Parkman Healthcare Partners LLC	235,385	$1.90M	0.5%	-10.4%	0.452%
11/14/2022	RTW Investments LP	3,985,910	$32.25M	0.7%	+0.6%	7.658%
11/14/2022	Point72 Asset Management L.P.	1,494,003	$12.09M	0.0%	-24.9%	2.870%
11/14/2022	RA Capital Management L.P.	7,000,000	$56.63M	1.2%	N/A	13.448%
11/14/2022	VR Adviser LLC	1,200,000	$9.71M	1.4%	N/A	2.305%
11/14/2022	MetLife Investment Management LLC	18,890	$0.15M	0.0%	N/A	0.036%
11/8/2022	Sofinnova Investments Inc.	797,262	$6.45M	0.4%	N/A	1.944%
11/8/2022	International Biotechnology Trust PLC	193,741	$1.56M	0.5%	+20,315.3%	0.472%
11/7/2022	Arizona State Retirement System	10,280	$83K	0.0%	N/A	0.025%
11/1/2022	Monashee Investment Management LLC	200,000	$1.62M	0.6%	N/A	0.488%
10/26/2022	Allspring Global Investments Holdings LLC	9,176	$74K	0.0%	N/A	0.022%
8/16/2022	International Biotechnology Trust PLC	949	$0.19M	2.0%	-98.9%	0.002%
8/16/2022	Delphia USA Inc.	11,784	$58K	0.0%	N/A	0.029%
8/15/2022	Point72 Asset Management L.P.	1,988,800	$9.75M	0.0%	+511.9%	4.869%
8/11/2022	Healthcare of Ontario Pension Plan Trust Fund	17,000	$83K	0.0%	N/A	0.042%
8/5/2022	Cowen AND Company LLC	2,385,885	$11.69M	1.1%	-30.9%	5.841%
7/29/2022	Tekla Capital Management LLC	58,537	$0.29M	0.0%	-24.3%	0.143%
7/29/2022	SG Americas Securities LLC	13,173	$65K	0.0%	+207.1%	0.032%
7/12/2022	Country Trust Bank	30,186	$0.15M	0.0%	-14.2%	0.074%
6/30/2022	Amalgamated Bank	3,324	$79K	0.0%	N/A	0.008%
5/20/2022	International Biotechnology Trust PLC	82,741	$0.83M	0.2%	+35.6%	0.203%
5/17/2022	RTW Investments LP	3,611,194	$85.41M	1.8%	-6.6%	8.840%
5/17/2022	Rock Springs Capital Management LP	434,590	$10.28M	0.3%	-4.9%	1.064%
5/16/2022	Blackstone Inc.	9,500	$0.23M	0.0%	N/A	0.023%
5/16/2022	Deep Track Capital LP	650,000	$15.37M	1.0%	-13.3%	1.591%
5/16/2022	Paradigm Biocapital Advisors LP	212,961	$5.04M	1.3%	N/A	0.521%
5/16/2022	Suvretta Capital Management LLC	2,613,412	$61.81M	1.9%	+10.0%	6.398%
5/13/2022	Parkman Healthcare Partners LLC	164,453	$3.89M	1.1%	-34.2%	0.403%
5/12/2022	Monashee Investment Management LLC	236,991	$5.60M	1.6%	-13.2%	0.583%
5/9/2022	Swiss National Bank	62,400	$1.48M	0.0%	+11.0%	0.154%
5/4/2022	Victory Capital Management Inc.	28,907	$0.28M	0.0%	N/A	0.071%
4/29/2022	SG Americas Securities LLC	4,289	$0.10M	0.0%	-63.8%	0.011%
4/29/2022	Nisa Investment Advisors LLC	17,200	$0.41M	0.0%	+628.8%	0.042%
4/21/2022	Strs Ohio	6,800	$0.16M	0.0%	-12.8%	0.017%
4/20/2022	Belvedere Trading LLC	15,785	$0.20M	0.0%	N/A	0.039%
2/25/2022	AlphaCentric Advisors LLC	28,500	$0.50M	0.1%	N/A	0.070%
2/15/2022	UNC Management Company Inc.	23,708	$0.42M	0.3%	N/A	0.058%
2/15/2022	Sofinnova Investments Inc.	617,670	$10.93M	0.6%	+1,111.0%	1.523%
2/15/2022	Cinctive Capital Management LP	36,120	$0.64M	0.0%	N/A	0.089%
2/15/2022	Darwin Global Management Ltd.	317,428	$5.62M	0.9%	+833.7%	0.783%
2/15/2022	Adage Capital Partners GP L.L.C.	1,720,000	$30.43M	0.1%	+45.8%	4.242%

Data available starting January 2016

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy is under phase III clinical trial; and pociredir, a fetal hemoglobin inducer for the treatment of sickle cell disease and beta-thalassemia is under phase I clinical trial. The company is also discovering drug targets for the treatments of rare neuromuscular, muscular, central nervous system, and hematologic disorders, as well as cardiomyopathies and pulmonary diseases. Fulcrum Therapeutics, Inc. has collaboration and license agreement with Acceleron Pharma Inc. to identify biological targets to modulate specific pathways associated with a targeted indication within the pulmonary disease space; and MyoKardia, Inc. to discover and develop therapies for the treatment of genetic cardiomyopathies. Fulcrum Therapeutics, Inc. was Incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $7.28

$7.18

$7.44

50 Day Range

MA: $9.41

$6.84

$12.00

52 Week Range

Now: $7.28

$2.43

$13.70

Volume

347,954 shs

Average Volume

646,631 shs

Market Capitalization

$452.45 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.29

Who are the company insiders with the largest holdings of Fulcrum Therapeutics?: Fulcrum Therapeutics' top insider investors include:
Ra Capital Management, LP (Major Shareholder)
Robert J Gould (Director)
Robert J Gould (CEO)
Greg Tourangeau (Insider)
Greg Tourangeau (VP)
Learn More about top insider investors at Fulcrum Therapeutics.
Who are the major institutional investors of Fulcrum Therapeutics?: Fulcrum Therapeutics' top institutional shareholders include:
Mass General Brigham Inc — 0.33%
Denali Advisors LLC — 0.04%
Learn More about top institutional investors of Fulcrum Therapeutics stock.
Which major investors are selling Fulcrum Therapeutics stock?: Within the previous quarter, FULC stock was sold by these institutional investors:
Denali Advisors LLC
In the previous year, company insiders that have sold Fulcrum Therapeutics company stock include:
Ra Capital Management, LP (Major Shareholder)
Robert J Gould (Director)
Learn More investors selling Fulcrum Therapeutics stock.
Which major investors are buying Fulcrum Therapeutics stock?: In the previous quarter, FULC stock was acquired by institutional investors including:
Mass General Brigham Inc

He Is Giving Away Bitcoin

From Crypto Swap Profits | Ad

>> Register right here

FULC Insider Trading

Fulcrum Therapeutics Insider Trading History Chart

Fulcrum Therapeutics Share Price & Price History

Fulcrum Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Fulcrum Therapeutics (NASDAQ:FULC)

Institutional Buying and Selling by Quarter

Fulcrum Therapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Fulcrum Therapeutics?

Who are the major institutional investors of Fulcrum Therapeutics?

Which major investors are selling Fulcrum Therapeutics stock?

Which major investors are buying Fulcrum Therapeutics stock?